IMF celebrates ODAC's historic decision on MRD testing as an early endpoint for accelerated myeloma drug approval. 10 yrs of IMF research led by Dr. Durie & i2TEAMM; & U of Miami Sylvester Comprehensive Cancer Center contributed to this decision. Bruno Paiva Nikhil C. Munshi, MD

I know we acknowledge and thank the clinicians - Statisticians, Patients, and Patient Orgs have played a significant role - Sean Devlin of Memorial Sloan Kettering Cancer Center , Qian Shi or Mayo Myeloma, and many others who made this ODAC positive vote possible thank you! #mms #mmMRD

MRD as an official endpoint for accelerated approval ODAC votes 12-0 great work by all congratulations!!

Getting MRD as an endpoint was a great partnership between academia and industry and patient organization. A model to follow. Patients are three winner. Vincent Rajkumar #@NoopurRajeMD #myelomasociety

ODAC Votes -12-0 to use MRD as an endpoint
ODAC team comments
-I have never before seen this effort
-Herculean effort
-15 years
-blueprint for other biomarkers
-a precedent for other cancers
-raises the bar higher :)

-Hearty congrats to the #i2TEAMM
-Thx C. Ola Landgren, M.D.…

Keynote speaker for the San Fran PFS will be Ajai Chari a leader in #immunotherapy for #myeloma . It’s not too late to register. Hope to see you there. #mmsm
International Myeloma Foundation
myeloma.org/events/imf-pat…

Excellent #MMsm news - two expanded 🇺🇸 CAR-T approvals today!

⚠️ 'Brain-to-brain-to-vein' time likely 4 months including initial referral to CAR-T center & logistics.

For pts who might need early CAR-T (functional high-risk) or just interested, we're happy to see them early!

Congratulations to MSK’s Urvi Shah for participating in the 5K run at #AACR24 ! What a way to kick off the weekend.

Agree great news for (insured) patients in USA. Can we (🌏🌎) agree to work harder to acheive more for other regions e.g Daratumumab/ Carfilzomib/pomalidomide for Myeloma New Zealand leukaemia.org.nz Australasian Leukaemia & Lymphoma Group (ALLG) Vincent Rajkumar Beth Faiman PhD Monica Morris amongst many more

I filmed a video for PBS on screening and diagnosing multiple myeloma for primary care providers. It will air on PBS - Detroit Public Television on 4/7 at 10:30am and 4/11 at 2:30pm

Multiple Myeloma I Primary Care with Dr. Lonnie Joe - 801 youtu.be/7YDzIl3DloU?si… via YouTube

Amazing day at Great Debates and Updates in Heme Malignancies in NYC. Blessed to chair the day with friends and myeloma gurus Adriana Rossi Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Gareth Morgan Ashley Rosko DavidSiegel Noa Biran Joshua Richter, MD, FACP Andrew Yee, MD brea lipe Noopur Raje #GDUHEM #mmsm

Truly an exciting era in #myeloma care. 🎉 🎉 🎉
#CART #MMsm .
Joseph Mikhael International Myeloma Foundation

This is exciting
- Many institutions in the US only have access to ide cel.
- In earlier lines due to better bridging Rx we can decrease CRS, ICANS

U.S. FDA Approves Abecma for TCE Relapsed or Refractory MM After 2 prior LOT morningstar.com/news/business-…

With Dr. Kyle (center) and Morie Gertz

Thanks to Shaji Kumar for taking the picture! Mayo Clinic

During Easter Sunday, I am grateful to those who choose to pay it forward in spite of themselves dealing with incurable disease #myeloma . Kent Oliver understood the value of personalized and contextual information and supported the Myeloma Knowledge Platform (MKP) CC: Sylviads